These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Biologic research in psychiatry]. Gay C Soins Psychiatr; 1983 Nov; (37):21-5. PubMed ID: 6560815 [No Abstract] [Full Text] [Related]
3. The overnight dexamethasone suppression test: clinical and theoretical review. Gwirtsman H; Gerner RH; Sternbach H J Clin Psychiatry; 1982 Aug; 43(8):321-7. PubMed ID: 7047505 [TBL] [Abstract][Full Text] [Related]
4. Association of monoamine oxidase A and serotonin transporter gene functional variants with intellectual disability related behavioral problems. Bhowmik AD; Mahapatra G; Dutta S; Shaw J; Sinha S; Mukhopadhyay K Psychiatr Genet; 2012 Jun; 22(3):152. PubMed ID: 21934643 [No Abstract] [Full Text] [Related]
5. [Peripheral biological markers in psychiatry: value of epidemiologic studies?]. Boulenger JP; Zarifian E Rev Epidemiol Sante Publique; 1985; 33(4-5):361-7. PubMed ID: 2869552 [TBL] [Abstract][Full Text] [Related]
6. Dexamethasone suppression test in psychiatry. Cápová E; Libiger J; Zapletálek M Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1987; 30(2):259-77. PubMed ID: 3328277 [No Abstract] [Full Text] [Related]
7. Screening young adults for psychiatric vulnerability: a preliminary comparison of biological and clinical measures. Haier RJ; Buchsbaum MS; Murphy DL Psychopharmacol Bull; 1979 Jan; 15(1):7-9. PubMed ID: 419263 [No Abstract] [Full Text] [Related]
8. [The dexamethasone test today. Discussion, critique and reflexions on the place and significance of the test in psychiatry]. Rigal J; Bendetowicz P; Rashedi M; Laval M Ann Med Psychol (Paris); 1987 Apr; 145(4):366-71. PubMed ID: 3674625 [No Abstract] [Full Text] [Related]
10. Catecholamine metabolism. From molecular understanding to clinical diagnosis and treatment. Overview. Boulton AA; Eisenhofer G Adv Pharmacol; 1998; 42():273-92. PubMed ID: 9327897 [No Abstract] [Full Text] [Related]
11. [Genetic polymorphism of a MAO in mental disorders]. Tylec A; Stryjecka-Zimmer M; Kucharska-Pietura K Psychiatr Pol; 2007; 41(4):485-93. PubMed ID: 18046979 [TBL] [Abstract][Full Text] [Related]
12. Combined dexamethasone suppression/corticotropin-releasing hormone stimulation test and antidepressants: different antidepressants may produce different effects. Sher L Med Hypotheses; 2006; 66(6):1248-9. PubMed ID: 16540260 [No Abstract] [Full Text] [Related]
14. Clinical utilization of the dexamethasone suppression test in an inpatient setting. Baxter LR; Fairbanks L; Gerner RH J Clin Psychiatry; 1984 Sep; 45(9):393-6. PubMed ID: 6469925 [TBL] [Abstract][Full Text] [Related]
15. [Genetic polymorphism of COMT in mental disorders]. Tylec A; Stryjecka-Zimmer M; Kucharska-Pietura K Psychiatr Pol; 2007; 41(4):473-83. PubMed ID: 18046978 [TBL] [Abstract][Full Text] [Related]
16. [Nosographic divergences and semeiologic convergences. A unified approach within the framework of a protocol of psychologico-clinical and biological exploration]. Macher JP; Fornari P; Crocq MA; Duval F; Hassler MC; Rebourg C; Fleig C Ann Med Psychol (Paris); 1984; 142(7):1011-6. PubMed ID: 6524801 [No Abstract] [Full Text] [Related]